Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.2 EUR
127.00 M EUR
684.60 M EUR
565.87 K
About BIOTEST AG
Sector
CEO
Peter Janssen
Headquarters
Dreieich
Website
Founded
1946
ISIN
DE0005227201
FIGI
BBG012GNSTQ4
Biotest AG engages in the development, manufacture, and marketing of plasma proteins and biotherapeutic drugs. It operates through the following segments: Therapy, Plasma and Services, and Other. The Therapy segment develops and produces blood plasma-based immunoglobulins, clotting factors, and albumins which are used to treat diseases of the immune system, haematological diseases, and in intensive care medicine. The Plasma and Services segment includes the areas of plasma sales and contract manufacturing. The Other segment refers to the merchandise business. The company was founded by Carl Adolf Schleussner and Hans Schleussner in 1946 and is headquartered in Dreieich, Germany.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0N6Z is 42.0 EUR — it hasn't changed in the past 24 hours. Watch BIOTEST AG NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange BIOTEST AG NPV stocks are traded under the ticker 0N6Z.
0N6Z stock hasn't changed in a week, the last month showed zero change in price, over the last year BIOTEST AG NPV has showed a −2.32% decrease.
0N6Z reached its all-time high on Jan 7, 2022 with the price of 44.0 EUR, and its all-time low was 19.6 EUR and was reached on Apr 1, 2020. View more price dynamics on 0N6Z chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0N6Z stock is 0.00% volatile and has beta coefficient of 0.07. Track BIOTEST AG NPV stock price on the chart and check out the list of the most volatile stocks — is BIOTEST AG NPV there?
Today BIOTEST AG NPV has the market capitalization of 1.65 B, it has increased by 0.88% over the last week.
Yes, you can track BIOTEST AG NPV financials in yearly and quarterly reports right on TradingView.
BIOTEST AG NPV is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
0N6Z net income for the last quarter is 9.70 M EUR, while the quarter before that showed 29.50 M EUR of net income which accounts for −67.12% change. Track more BIOTEST AG NPV financial stats to get the full picture.
Yes, 0N6Z dividends are paid annually. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (TTM)% is 0.10%. Tracking BIOTEST AG NPV dividends might help you take more informed decisions.
As of Nov 12, 2024, the company has 2.43 K employees. See our rating of the largest employees — is BIOTEST AG NPV on this list?
Like other stocks, 0N6Z shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOTEST AG NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOTEST AG NPV technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOTEST AG NPV stock shows the buy signal. See more of BIOTEST AG NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.